Oppenheimer maintained its Perform rating and trimmed its price target on MAKO Surgical (NASDAQ: MAKO) from $14 to $13 following ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE